Atherosclerotic Disease: Pathogenesis and Approaches to Management.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37541708.
- Also identified by DOI 10.1016/j.mcna.2023.04.004 and PMC identifier 10547111.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atherosclerotic disease, including stroke and myocardial infarction, is the leading cause of morbidity and mortality worldwide. Atherosclerotic plaque formation occurs in the setting of excess oxidative and hemodynamic stress and is perpetuated by smoking, poor diet, dyslipidemia, hypertension, and diabetes. Plaque may rupture, resulting in acute thrombotic events. Smoking cessation, lifestyle modification, risk factor optimization, and antithrombotic therapies are the mainstays of atherosclerotic disease management and are the cornerstones to reduce morbidity and mortality in this high-risk patient population. Novel therapeutics are in development and will add to the growing armamentarium available to physicians who manage atherosclerotic disease.
Medical subject headings
- Atherosclerosis
- Myocardial Infarction
- Diabetes Mellitus